Cost of Care at NCI-Designated Comprehensive Cancer Centers Vs. Other Treatment Sites for Young Adults with Newly-Diagnosed Acute Lymphoblastic Leukemia (ALL)

Conclusions: Using a commercial insurance database, we find that for patients diagnosed with ALL between the ages of 22y and 39y, the costs paid by the health plan are 3 times higher for those receiving care at an NCI-designated CCC as compared to a non-CCC site. Along the same lines, out of pocket costs are 1.7 times higher for those receiving care at an NCI-designated CCC as compared to a non-CCC site. The difference in cost is highest during the first year of therapy. We are currently examining the details of what drives the higher cost of care at CCC.Figure 1.DisclosuresLyman: Generex Biotechnology: Membership on an entity's Board of Directors or advisory committees; Amgen: Other: Research support; Halozyme; G1 Therapeutics; Coherus Biosciences: Consultancy.

Source: Blood - November 21, 2018 Category: Hematology Authors: Wolfson, J. A., Bhatia, S., Ginsberg, J., Becker, L., Bernstein, D., Henk, H., Lyman, G. H., Nathan, P., Puccetti, D., Wilkes, J. J., Winestone, L. E., Kenzik, K. Tags: 902. Health Services Research-Malignant Diseases: Poster II Source Type: research